Mackenzie Financial’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-97,684
Closed -$3.51M 1128
2019
Q4
$3.51M Sell
97,684
-100
-0.1% -$3.45K 0.01% 515
2019
Q3
$3.34M Sell
97,784
-600
-0.6% -$19.2K 0.01% 525
2019
Q2
$2.75M Sell
98,384
-773
-0.8% -$21.5K 0.01% 567
2019
Q1
$3.07M Buy
+99,157
New +$2.65M 0.01% 668
2016
Q4
Sell
-25,429
Closed -$505K 690
2016
Q3
$505K Sell
25,429
-2,600
-9% -$45.4K ﹤0.01% 495
2016
Q2
$400K Buy
28,029
+6,800
+32% +$104K ﹤0.01% 790
2016
Q1
$329K Buy
21,229
+2,500
+13% +$35.8K ﹤0.01% 718
2015
Q4
$323K Sell
18,729
-7,150
-28% -$103K ﹤0.01% 742
2015
Q3
$315K Sell
25,879
-4,900
-16% -$62.8K ﹤0.01% 727
2015
Q2
$371K Sell
30,779
-5,871
-16% -$57.8K ﹤0.01% 717
2015
Q1
$307K Hold
36,650
﹤0.01% 724
2014
Q4
$280K Buy
36,650
+1,930
+6% +$13.8K ﹤0.01% 700
2014
Q3
$239K Sell
34,720
-2,000
-5% -$14.9K ﹤0.01% 687
2014
Q2
$304K Buy
36,720
+9,480
+35% +$74.1K ﹤0.01% 626
2014
Q1
$220K Buy
+27,240
New +$218K ﹤0.01% 635

Other funds holding LMAT

Mackenzie Financial's LMAT Position: Q1 2020 in Review

Mackenzie Financial sold out of LeMaitre Vascular (LMAT) in Q1 2020, closing a stake of 97,684 shares — an estimated $3.51M sold.

Mackenzie Financial first reported a position in LMAT in Q1 2014 and held it in 15 quarters. The position peaked at $3.51M in Q4 2019. 144 funds tracked by Wall St. Rank hold LMAT as of Q1 2020.

  • Mackenzie Financial reported no remaining LeMaitre Vascular position as of Q1 2020 after selling out during the quarter.
  • Mackenzie Financial sold 97,684 LeMaitre Vascular shares in Q1 2020, an estimated $3.51M.
  • Mackenzie Financial first reported a position in LeMaitre Vascular in Q1 2014 and held it in 15 quarters.
  • Mackenzie Financial's LeMaitre Vascular position peaked at $3.51M in Q4 2019.
  • 144 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2020.

Based on Mackenzie Financial's 13F filing for Q1 2020, filed 14 May 2020.